Founder Chief Executive Officer

Dr. Christopher Tang, the founder and CEO of Vaxdome, is a renowned figure in the field of vaccine development. With his team, they pioneered the creation of DNA vaccines, noninvasive nasal and skin-patch vaccines, as well as innate-adaptive immunity duo vaccines. They also developed in vivo cytotoxicity assays, among other groundbreaking contributions. Dr. Tang earned his PhD from Indiana University and started his career as an assistant instructor/instructor at the University of Texas Southwestern Medical Center. He then moved on to become an assistant/associate professor at the University of Alabama at Birmingham (UAB). In 1997, he established Vaxin Inc. on the UAB campus, which is now known as Altimmune, Inc. (NASDAQ: ALT). Continuing his success, Dr. Tang also founded Vaxdome Inc. on the University of North Texas Health Science Center campus in 2019. His expertise and dedication have propelled him to the forefront of vaccine research and development.

Board of Director

G. Michael Alder became a member of the Vaxdome board of directors in January 2024. With an impressive and remarkable career as an entrepreneurial innovator, Alder has made significant contributions to the field. From 2006 to 2023, he held the position of Director in the Office of Technology Transfer at Brigham Young University. Additionally, he has played a pivotal role in the establishment of Vaxin Inc., along with the founder and CEO of Vaxdome, Dr. Tang. Together, they co-founded Vaxin Inc. on the UAB campus in 1997. Alder served as the first CEO of Vaxin from 1997 to 1999, helping to shape its early success.

Patent Attorney

Edwin S. Flores, a highly qualified patent attorney with both a PhD and JD, is an integral part of the esteemed law firm Chalker Flores, LLP, based in Dallas, Texas. With his extensive educational background and expertise in patent law, Flores offers valuable legal counsel and representation to clients seeking protection for their inventions and intellectual property. His dual degrees in immunology and law provide him with a unique advantage in understanding the technical aspects of inventions and effectively navigating the complex patent application process. Flores's dedication to his clients and commitment to excellence have earned him a reputation as a trusted and skilled patent attorney in the Dallas area.

VaxDome’s Patent Portfolio

· U.S. Provisional Patent “Neuraminidase-inhibited influenza virus” (Filed on 09/20/2022; serial No. 63/408,387)

· U.S. Utility Patent “Neuraminidase-inhibited influenza virus” (Filed on 09/20/2023; serial No. 18/470,999)

· PCT Patent “Neuraminidase-inhibited influenza virus” (Filed on 09/20/2023; serial No. PCT/US2023/074686)

· U.S. provisional patent “Cellular immunity assay by topical application of pathogen particles” (Filed on 11/22/2022; serial No. 63/427,231)

· U.S. Utility Patent “Cellular immunity assay by topical application of pathogen particles” (Filed on 11/20/2023; serial No. 18/513,946)Write your text here...

Contact

De-chu Christopher Tang, PhD

Founder CEO

VaxDome Inc.

University of North Texas Health Science Center

3500 Camp Bowie Blvd. EAD-116

Fort Worth, Texas 76107

USA

Email: dechutang@vaxdome.com

Website: www.vaxdome.website